MYC and breast carcinoma: In a study on breast cancer cell lines, Sengupta et al. had demonstrated that in multiple aromatase inhibitor-resistant MCF-7 cancer cell lines, the levels of cMYC mRNA and proteins were significantly higher than the parental MCF-7 cell line.